44 results on '"Grouzmann E"'
Search Results
2. [PP.27.04] COMPARISON BETWEEN CORTISOL, FREE METANEPHRINE AND THE FREE/TOTAL METANEPHRINE RATIO TO ASSESS SELECTIVITY OF ADRENAL VEIN SAMPLING
3. Serotonin, Melatonin and Their Metabolites Measured in Plasma by a New LC-MS/MS Assay In Healthy Volunteers
4. Catecholamine Metabolism in a Shetland Pony with Suspected Pheochromocytoma and Pituitary Pars Intermedia Dysfunction
5. Sympathetic activity and early mobilization in patients in intensive and intermediate care with severe brain injuries: a preliminary prospective randomized study
6. [OP.7D.04] CHANGES IN RENAL HEMODYNAMIC AND TUBULAR SODIUM HANDLING ONE YEAR AFTER TRANSCATHETER RENAL DENERVATION IN RESISTANT HYPERTENSION
7. P3-19: Treatment with candesartan unmasks higher urinary norepinephrine excretion in white coat hypertensive patients compared to healthy normotensive participants
8. 9C.09
9. Urinary and Plasma Catecholamines and Metanephrines in Dogs with Pheochromocytoma, Hypercortisolism, Nonadrenal Disease and in Healthy Dogs
10. OC005—Biases On The Administered Parenteral Doses Of An Experimental Drug During Phase I Clinical Trials
11. Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans
12. The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans
13. Plasma fractionated total metanephrines for biochemical diagnosis of neuroblastoma.
14. Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors
15. Interaction between neuropeptide Y (NPY) and brain‐derived neurotrophic factor in NPY‐mediated neuroprotection against excitotoxicity: a role for microglia
16. Implication of Dipeptidylpeptidase IV Activity in Human Bronchial Inflammation and in Bronchoconstriction Evaluated in Anesthetized Rabbits
17. The Putative Neuroprotective Role of Neuropeptide Y in the Central Nervous System
18. P211 - Caractérisation de nouveaux peptides dérivés des chromogranines comme marqueurs diagnostiques des phéochromocytomes
19. BIOCHEMICAL DIAGNOSIS OF PHEOCHROMOCYTOMA
20. PLASMA CATECHOLAMINES AND HYPERTENSION IN HEMODIALYSIS
21. PLASMA CATECHOLAMINES AND HYPOTENSION IN HEMODIALYSIS Michel Burnier, Division of Nephrology
22. Neuropeptide Y: the universal soldier
23. Plasma and cerebrospinal fluid concentrations of neuropeptide Y, serotonin, and catecholamines in patients under propofol or isoflurane anesthesia
24. The subtype 2 of angiotensin II receptors and pressure-natriuresis in adult rat kidneys
25. Dipeptidyl-peptidase IV secreted by Aspergillus fumigatus, a fungus pathogenic to humans
26. Intracellular staining of angiotensin receptors in the PVN and SON of the rat
27. Post-exercise Nasal Vasoconstriction and Hyporeactivity: Possible Involvement of Neuropeptide Y
28. Intranasal administration of neuropeptide Y in man: systemic absorption and functional effects
29. Neuropeptide Y secretion from a human insulinoma
30. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system
31. The immunological impairment of arcuate neuropeptide Y neurons by ricin A chain produces persistent decrease of food intake and body weight
32. Short-term effects of octreotide on blood pressure and plasma catecholamines and neuropeptide Y levels in patients with phaeochromocytoma: a placebo-controlled trial
33. Angiotensin-II mediates norepinephrine and neuropeptide-Y secretion in a human pheochromocytoma.
34. Angiotensin-II mediates norepinephrine and neuropeptide-Y secretion in a human pheochromocytoma
35. Interactions between NPY and its receptor: assessment using anti-NPY antibodies
36. Differential vascular effects of neuropeptide Y(NPY) selective receptor agonists
37. Centrally truncated neuropeptide Y analogues display Y1 selectivity and vasoconstrictor properties in vivo
38. Localization of neuropeptide Y and its flanking peptide in human renal tissue
39. Neuropeptide Y expression and regulation in a differentiated rat insulin-secreting cell line.
40. A sensitive and specific two-site, sandwich-amplified enzyme immunoassay for neuropeptide Y
41. In Vitro Effects of DuP 753, a Nonpeptide Angiotensin II Receptor Antagonist, on Human Platelets and Rat Vascular Smooth Muscle Cells
42. Characterization and Use of Four Anti-NPY Monoclonal Antibodies to Study NPY-Receptor Interaction
43. Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas
44. Plasma Neuropeptide Y Concentrations in Patients with Neuroendocrine Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.